Pregled bibliografske jedinice broj: 713492
SERUM FERRITIN CONCENTRATION IN SOLID TUMOR PATIENTS
SERUM FERRITIN CONCENTRATION IN SOLID TUMOR PATIENTS // Libri oncologici : Croatian journal of oncology, Vol 40 (2012), 1-5 (podatak o recenziji nije dostupan, članak, ostalo)
CROSBI ID: 713492 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
SERUM FERRITIN CONCENTRATION IN SOLID TUMOR PATIENTS
Autori
Skoko, Marija ; Mihić Lasan, Irena ; Culej, Jelena ; Krajačić Karas, Gorana ; Vučemilo, Tiha ; Šturm, Deana
Izvornik
Libri oncologici : Croatian journal of oncology (0300-8142) Vol 40
(2012);
1-5
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
ferritin ; cancer ; H-subunit ; iron
Sažetak
Ferritin is a positive acute phase reactant. It is produced and secreted by various cells such as hepatocytes, macrophages and cancer cells. This was a retrospective study which included 46 patients with solid tumors who were tested for ferritin level in plasma. The measured value of the ferritin concentration in plasma of patients was in the range from 5.98 to 850.78 ug/L, and the average measured value was 174, 62ug/L. For the control group, we also included 46 subjects. The measured value of ferritin in the control group was in the range from 5.94 to 351.54ug/L, and the average measured value was 63.17ug/L. There is a statistically significant difference between the two groups. Our data shows that the highest level of ferritin was measured in patient with breast cancer. By many studies done until now it is shown that iron metabolism is dysregulated in cancer, and that changes occur in both intracellular and extracellular ferritin.
Izvorni jezik
Engleski
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus